Alzamend Neuro, Inc. (ALZN) is a publicly traded company in the Unknown sector. Across all available filings, 8 corporate insiders have executed 190 transactions totaling $21.6M, demonstrating a bullish sentiment with $16.8M in net insider flow. The most recent transaction on Dec 23, 2025 involved a sale of 1,851 shares valued at $3.8K.
No significant insider buying has been recorded for ALZN in the recent period.
No significant insider selling has been recorded for ALZN in the recent period.
Based on recent SEC filings, insider sentiment for ALZN is bullish with an Insider Alignment Score of 89/100 and a net flow of $16.8M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Alzamend Neuro, Inc. (ALZN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 8 insiders are actively trading ALZN stock, having executed 190 transactions in the past 90 days. The most active insider is Milton C. Ault III (Executive), who has made 162 transactions totaling $25.0M.
Get notified when executives and directors at ALZN file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 23, 2025 | C. Ault Milton III | Executive | Sale | 1,851 | $2.07 | $3.8K | |
| Dec 23, 2025 | C. Ault Milton III | Executive | Sale | 1,851 | $2.07 | $3.8K | |
| Dec 19, 2025 | B. Horne William | Executive | Sale | 3,333 | $2.12 | $7.1K | |
| Oct 23, 2025 | Fahey Mcgrath Lynne | Executive | Sale | 30 | $2.29 | $69 | |
| Oct 9, 2025 | C. Ault Milton III | Executive | Sale | 20,397 | $2.32 | $47.3K | |
| Oct 8, 2025 | C. Ault Milton III | Executive | Conversion | 61,743 | $2.32 | $143.2K | |
| Oct 8, 2025 | C. Ault Milton III | Executive | Sale | 101,394 | $2.44 | $247.4K | |
| Oct 7, 2025 | C. Ault Milton III | Executive | Sale | 57,379 | $2.49 | $142.9K | |
| Oct 7, 2025 | C. Ault Milton III | Executive | Conversion | 100,000 | $2.32 | $232.0K | |
| Oct 6, 2025 | C. Ault Milton III | Executive | Sale | 82,033 | $2.45 | $201.0K | |
| Oct 3, 2025 | C. Ault Milton III | Executive | Sale | 65,903 | $2.44 | $160.8K | |
| Oct 3, 2025 | C. Ault Milton III | Executive | Conversion | 100,000 | $2.32 | $232.0K | |
| Oct 2, 2025 | C. Ault Milton III | Executive | Sale | 20,686 | $2.39 | $49.4K | |
| Oct 1, 2025 | C. Ault Milton III | Executive | Conversion | 100,000 | $2.32 | $232.0K | |
| Oct 1, 2025 | C. Ault Milton III | Executive | Sale | 36,777 | $2.35 | $86.4K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 120 | $19.2M | 76.0% |
Sale(S) | 35 | $2.4M | 9.4% |
Conversion(C) | 10 | $2.1M | 8.3% |
Other(J) | 6 | $1.6M | 6.2% |
Exercise(M) | 19 | $0 | 0.0% |
Insiders at Alzamend Neuro, Inc. are accumulating shares at an accelerated pace. With 8 insiders making 190 transactions totaling $19.2M in purchases versus $2.4M in sales, the net buying activity of $16.8M signals strong executive confidence. Milton C. Ault III (Executive) leads the buying activity with $25.0M in transactions across all time.